chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had previous flu vaccines without incident.   This was a required vaccination given at the hospital that I worked in on Friday morning 11.9.2018 at approximately 8am.   Vaccination site without incident.   The following day, on Saturday 11.10.2018, I started experiencing severe joint pain in my elbows, shoulders, hips and knees.   I was barely able to walk to perform ADL's for the entire day as well as Sunday.   Severe pain continued and was medicated with alternating Tylenol and Motrin; ice packs and other comfort measures.  I was seen at the Urgent Care on 11.12.2018 and was prescribed prednisone for the condition and returned to work later that week.    Never previously nor since has joint pain been a  condition that I have suffered from.
Information has been received from a registered nurse concerning a female patient who on approximately 23-OCT-2007 about 2 weeks ago, was vaccinated IM with a second 0.5mL dose of GARDASIL. On approximately 23-OCT-2007, the patient fainted after receiving the vaccine. Unspecified medical attention was sought. Within minutes and without any intervention at the office, the patient recovered. It was reported that the patient did not experience any events after her first dose of the vaccine. No product quality was involved. Additional information has been requested.
Swelling, intense heat, and blisters in 2 Diameter around injection point on 4/2/2021 lasting 36 hours.  This reaction was no longer present after 4/5/2021.  Swelling, intense heat, and injection site pain in 4" Diameter around injection point starting 4/9/2021 and ongoing at the time of this report.
Swelling, redness and warmth to right lower leg noticed on April 2nd 2021.
First dose / 13-December-2020 / planning / second dose this weekend; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 0.5ml on 13th December 2020 intramuscularly at pharmacy).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follow: The patient was the reporter. The age at vaccination was not applicable for this report. Till the time of reporting. the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The patient was planning to receive her second dose this weekend. The VARES details were reported for 1st dose. The reporter consented to follow up. This case was linked with US2021166473, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021166473:Same reporter. Husband's case.
metallic taste in mouth; steel made fork and nail cutter stick to her body (chest and right arm); abdominal pain; pain in my joints; Decrease in appetite/loss of appetite; intesnse freezing cold chils for 2 days/third day moderate chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Decrease in appetite/loss of appetite), DYSGEUSIA (metallic taste in mouth), STICKY SKIN (steel made fork and nail cutter stick to her body (chest and right arm)), ABDOMINAL PAIN (abdominal pain) and CHILLS (intesnse freezing cold chils for 2 days/third day moderate chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 06A21A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE and SIMVASTATIN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced DECREASED APPETITE (Decrease in appetite/loss of appetite). 29-Mar-2021, the patient experienced CHILLS (intesnse freezing cold chils for 2 days/third day moderate chills). On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth), STICKY SKIN (steel made fork and nail cutter stick to her body (chest and right arm)), ABDOMINAL PAIN (abdominal pain) and ARTHRALGIA (pain in my joints). On 31-Mar-2021, CHILLS (intesnse freezing cold chils for 2 days/third day moderate chills) had resolved. At the time of the report, DECREASED APPETITE (Decrease in appetite/loss of appetite), DYSGEUSIA (metallic taste in mouth) and STICKY SKIN (steel made fork and nail cutter stick to her body (chest and right arm)) outcome was unknown and ABDOMINAL PAIN (abdominal pain) and ARTHRALGIA (pain in my joints) had not resolved.            No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up Information Received on 16-JUN-2021  contains No NewInformation. On 29-Jun-2021: Added new Events such as Joint pain and Abdominal pain.
PATIENT REPORTED EXTREME SWELLING IN HER ARM, ALL THE WAY DOWN TO HER ELBOW. LIMITED RANGE OF MOTION. WENT IN TO HAVE IT EXAMINED BY A DOCTOR, AND THEY ALL AGREE IT LOOKS LIKE SIRVA.
Admin. at roughly 3:37 pm 6/1/15 (June 1st). Patient presented w/swelling at injec site (relatively large) pinkish and warmth to touch (on 6/3/15). Patient went to MD and was prescribed cephalexin 500,g 1 cap Q8H for 7 days. MD believes it's due to infection at site.
Patient had a Tdap injection on 04/05/13. She now has a "bump" on her left deltoid. No other symptoms other then the "bump" she has now.
Muscle soreness; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) and MYALGIA (Muscle soreness) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 14-May-2021, the patient experienced MYALGIA (Muscle soreness). On 03-Apr-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. At the time of the report, MYALGIA (Muscle soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include High blood pressure medications. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-133302 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021. Event outcome has been  updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-133302:mother
G5P3 at the time. One second trimester loss 2015 placental abruption. No history of early miscarriages.  LMP 1/29/2021    Positive urine pregnancy 2/26/2021.  Miscarriage/bleeding 3/5/2021. Negative urine pregnancy 3/8/2021
Pt recv vax on 7/20/78 and sustained permanent brain damage manifested by mental retardation, hypotonicity, coordination problems, ataxia, lethargy and developmental delay.
1/8/21. Second Pfizer dose. Immediately felt soreness in the arm radiating to the neck. Possible from technique vs actual vaccine 1807 - Neck pain, 3/10, left arm pain 3/10. Left cervical lymph node inflamed 2035 - ringing on right ear 2244 - dizziness 1/9/21. Injection site 1cm diameter bump. Pain in left arm, neck, shoulder 1156 - headache, sharp right parietal 3/10 1730 - pain 8/10 on left upper arm, radiating to lower arm, shoulder, neck. Improved to 4/10 after Advil 800mg once. 1/10/21.  Woke up with pain in left arm 7/10. Injection site has induration of 4cm, reddened, warm, tender to touch. Pain improved after Advil 800mg and Tylenol 500mg
Following a Phizer Covid vx patient fainted. During the fall patient hit his jaw on the sharps container on the left side of his mouth. A small laceration was noted. Patient denies headache or pain anywhere other than his jaw. Slight abrasion noted to left elbow. 98/52 P 89  SPO2 95%
Received DTaP, IPV, MMR on 9/1/04. On 9/2/04 the left deltoid muscle was found by the mother to be very red, hot and swollen. The redness extended over the upper entire half of the left arm.
Information has been received from a registered nurse concerning a patient's granddaughter who was vaccinated with a dose of VARIVAX (Merck) as a child, and developed several very mild cases of chicken pox post vaccination. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
The patient developed autism symptoms from absolutely healthy. He was diagnosed "moderate autism" on 03/28/2008.  9/5/08 Reviewed PCP office records of 2/6/06-8/2/07. FINAL DX: none provided Records reveal patient experienced excellent health in 2006.  RTC 1/07 w/pharyngitis, 3/20/07 w/URI & 4/07 w/pharyngitis & OM.  May, 2007 parent expressed concern re development.  8/07 noted to have atopic dermatitis.  9/16/08 Received psychological report from parent for 3/28/2008. FINAL DX:Autism spectrum disorder Records reveal patient experienced communication, play, motor/sensory & socialization delays as well as stereotyped behaviors.
Day after injection painful arm. Pain continued and after 2 weeks physician ordered xray and prescribed prednisone. Pain spread. Orthopedic visit with cortisone injection and MRI. Dec. 18 MRI results-frozen shoulder. Starting physical therapy 1/5/16.
recieve vaccine sat for a while left and came back to pharmacy having tingling in lips and lightheaded sat down for 15 minutes was ask if he wanted medical assistance , response was no, i suggested being checked by local er, he left, i called later to follow up with pt stated he was feeling much better
1/13/2021 12:00 PM: Patient received COVID-19 Vaccine. 1/14/2021 21:00: Nurse performed routine rounds and the patient appeared okay. 1/14/2021 22:00: CNA discovered patient unresponsive in bed, began CPR, and called 911. 1/14/2021 23:08: Pronounced deceased.
This spontaneous report was received from a medical assistant referring to a unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications. From 18-SEP-2017 to 20-SEP-2017, the patients were vaccinated with improperly stored doses of ROTATEQ orally, lot # M041768 with expiration date on 25-JUN-2018 and lot # N005617 with expiration date on 30-OCT-2018, (dose and route of administration were not provided) for prophylaxis. The doses of ROTATEQ were exposed to a temperature excursion of 32 degrees Fahrenheit (°F) to 35°F during a time frame of 2 hours 45 minutes which was detected by the data logger. There was no prior temperature excursion and no adverse events were reported. This is one of the two reports received from the same source. Sender's Comments: US-009507513-1709USA010565.
The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; This is a spontaneous report from a contactable consumer or other non hcp via a Pfizer-sponsored program. A 66-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on Jan2021 as dose 1, single and second dose via an unspecified route of administration on Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Reporter said that last 11Aug2021, her husband started to get sick and got diagnosed with COVID and has been in the surgical ICU for a month and in a ventilator for 2 weeks. An x-ray showed that the virus has ravaged his lungs and at this point, the doctors said it doesn't look like there's any way he's going to bounce back from this. Reporter also asked that she wanted to know how it's possible that her husband still got sick despite being vaccinated. She also wanted to know if Pfizer can assist in getting a lung transplant. The patient underwent lab tests and procedures which included x-ray: the virus has ravaged his lungs. The outcome of the events was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow up.
This was a delayed reaction that occurred 12 days after the initial vaccination.  The patient had a tennis ball sized area of redness that was warm to the touch and was also itchy.
STABLE ANGINA ANGINA, UNSPECIFIED ACUTE CORONARY SYNDROME, UNSPECIFIED
Pt experience red dry rash on back of neck in hair line. Pt was given RIG on 4Jun2011, along with rabies vaccine 4Jun2011, & 7Jun2011 and 11Jun2011. Pt noticed rash 9Jun2011 but waited until 13 Jun 11 to notify parents.
Incorrect product storage; No additional AE information.; This spontaneous report has been received from a nurse referring to a patient of unknown age. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.     On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S027465, with expiration date of 02-MAR-2021, 0.5 milliliter (strength, dose, route, frequency, and anatomical location were not provided) for prophylaxis. The vaccine was exposed to multiple temperature excursions that were called by a data logger. No adverse event reported.
Pt developed painful rash in left lower abdomen. Wrapping around to lower back w/ throbbing pain. Burning. Numbness - treated with VALTREX x 500mg & NEURONTIN 250mg.
pt recvd vax on 24AUG93 in afternoon-tender rt arm, swelling used ice & APAP; t101; react @ inject site to cont ice & APAP; 3cm flaming red, hot to touch, painful when to MD; MD told had reaction to tetanus;
injection site pain; right arm sore; right arm swollen; could not sleep; muscle aches; feels exhausted; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th May 2019 14:00, the patient received the 1st dose of Shingrix (intramuscular). In May 2019, 16 hrs after receiving Shingrix, the patient experienced exhaustion. On 20th May 2019, the patient experienced injection site pain, pain in arm, injection site swelling, insomnia and muscle pain. On an unknown date, the outcome of the injection site pain, pain in arm, injection site swelling, insomnia, muscle pain and exhaustion were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, pain in arm, injection site swelling, insomnia, muscle pain and exhaustion to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix at around 2 pm and 1 second after vaccination the patient experienced injection site pain. The patient reported that about 4 hours later, her arm became swollen at the injection site and was sore.  Ten hours after vaccination, the patient reported that she had difficulty sleeping due to muscles aches all night.  On 21st May 2019, the patient felt exhausted. The reporter did not consent to follow-up. Lot number was not known at time of report.
On Saturday, the day after I got the vaccine the only symptom I had was tiredness. I caught a cold from members of my household, so I spent the weekend with symptoms like sneezing and light fever that went away on Monday.  On Wednesday (5th day) around 10 am all my body started itching. I found out that I had a bad rash all over my body, it was redness in my chest, stomach, arms, back, and legs. Only some spots with hives but the redness migrated throughout to different areas during the day. I went to ER and while I was there my face started to swell. They gave me the following medication: (1) Famotidine 20 mg oral tablet, (3) dexamethasone 10 mg injectable solution, and (2) diphenhydramine hydrochloride 25 mg oral tablet. By the end of the day, all redness and swell disappeared. They prescribed my Prednisone 10 mg for 5 days to be taken 3 pills in the mornings.  On Thursday (6th day) I woke up with the top of my hands red but migrated to the arms after an hour. I took Prednisone as prescribed, but redness and hives kept appearing in different areas of my body, less than the day before but progressing. By 7 pm face started to swell again under my eyes and cheeks. Went to ER again and they asked me to take Benadryl 50mg at night with Famotidine 20 mg and keep taking it every 6-8 hours, (Famotidine every 12 hours) and continue with Prednisone as prescribed.  Today is Friday, the time is 11:30 am (7th day) and I already took Prednisone with Famotidine and so far, I don?t see any redness.
On 10/26/2017, I received employee vaccine in clinic conference room. Right arm was sore; and became increasingly painful over next few days. On 10/31/2017, notified my manager of sharp, radiating pain in my right arm that was bringing me close to tears. Area where shot was given in arm was swollen, hot & red. Recommended to see nurse, who examined and recommended seeing provider right away. Saw Dr. late afternoon in Urgent Care, was prescribed TYLENOL and 800mg ibuprofen, and something to prevent stomach from reacting to ibuprofen (Don't have with me, not remembering name) and icing area. Next day, 11/1/2017, in morning realized my right side of face had some numb areas, (right eyebrow to cheek bone) which seemed to progress to more areas on right side of face as the morning went on. Let my manager know I was having some additional symptoms, discussed with nurse as well; went to Clinic at 1pm to see Dr. to let her know of new symptoms and persisting pain & weakness in arm. Was admitted into hospital observation that afternoon. Dr stopped in to evaluate, said most likely combination of needle too close to nerve & chemical reaction to vaccine. 11/2/2017 MRI to brain & cervical area was done, results good, was released to go home. Given pain meds to take when needed; 11/6/17 Returned to work for couple hours, but experienced numbness in shoulder/forearm while typing/using mouse. Saw Dr. for after hospital check. Lab work to check inflammation. Prescribed muscle relaxer and I went home. Physical therapy also prescribed. 11/7/17 Saw Dr. at clinic; had EMG with good results, no long term nerve damage; anticipates 4-6 weeks to recover/heal. Follow up with physical therapy. 11/13/2017 Physical therapy appt at 4:15pm. Overall improving, still have arm discomfort / tenseness / weakness in arm.
Headache, Arthralgia & Fever Narrative: headache, arthralgia, fever 100.1;took Tylenol and ibuprofen.
Receive 0.3 ml of Pfizer vaccine. Discovered later that vial had been diluted with 1.6 ml instead of the recommended 1.8 ml normal saline. Tingling/numbness on same arm as injection.  Reports feeling odd.  Observed and symptoms resolved within 20 minutes.  Released home
pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate; Breast pain; Twingy; "itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection; Armpit pain; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cardiovascular disease, unspecified. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Cardiovascular disease, unspecified.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain). At the time of the report, PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (normal) No abnormalities were found.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked toMOD-2021-123400 (E2B Linked Report).; Sender's Comments:  MOD-2021-123400:dose 2
After administration, vaccine expiration date noted to be 8/8/2023. Patient called and notified, counseled on revaccination.
BURNING SENSATION IN ARM AFTER INJECTION THAT RADIATED TO OTHER ARM AND DOWN SPINE SORE TO TOUCH RIBS.  TINGLING IN UPPER SPINE FOR 2 WEEKS FOLLOWING INJECTION. CHILL. FEVER. FATIGUE.
I had the shots still got shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had the shots and still got shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.